Prudentia Sciences: Valuation, Funding & Investors
Prudentia Sciences is an AI-native platform focused on life sciences due diligence and dealmaking. The company leverages artificial intelligence to streamline evaluation and transaction processes for biotech and pharmaceutical investments, supporting informed decision-making in the life sciences sector.
Leadership & Board
- Current Number of Employees
- 27
- Current LinkedIn Followers
- 6,747
Latest Estimated Valuation
- Total Amount Raised
- $20M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $20M
- Latest Funding Round
- Series A
Company Momentum
PositivePrudentia Sciences LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Prudentia Sciences had 27 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Prudentia Sciences had 6,747 followers as of November 16, 2026. The number of followers increased by 43 (0.64%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 18, 2026 | Series A | $20.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| SignalFire | Series A |
| GV | Series A |
| Virtue | Series A |
| McKesson Ventures | Series A |
| Iaso Ventures | Series A |
Similar Companies
A snapshot of private companies similar to Prudentia Sciences, helping you discover and navigate related company profiles.







